Dexamethasone palmitate

地塞米松棕榈酸酯

Report date: 2026/03/17 20:00:15

Base Information

Drug NameDexamethasone palmitate
Drug Alias Name眼用皮质类固醇前药 - Santen SASOphthalmic corticosteroid prodrug - Santen SASDexamethasone palmitate intravitreal injectionCortijectNOVA-63035
ClassificationSmall molecules > Steroids
Mechanisms of ActionGlucocorticoid receptor agonists
TargetsGlucocorticoid receptor
Therapy Area/IndicationsOsteoarthritisArthritis, Rheumatoid
Global Approved IndicationsArthritis, Rheumatoid
Approved Indications in ChinaArthritis, Rheumatoid
Original Approved Country/TerritoryJapan
Original Approved Date1988/06/01
Country/TerritoryMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSanten Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGuangzhou Green Cross Pharmaceutical Co LtdMitsubishi Tanabe PharmaBeijing Tobishi Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsOsteoarthritisArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeA01AC02C05AA09D07AB19 +[11] 
Related LinksWikipediaDrugBankKEGG